- Home
- HSDT vs ACHV Comparison
HSDT vs ACHV Comparison
Compare HSDT & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSDT
- ACHV
- Stock Information
- Founded
- HSDT N/A
- ACHV N/A
- Country
- HSDT United States
- ACHV United States
- Employees
- HSDT N/A
- ACHV N/A
- Industry
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HSDT Health Care
- ACHV Health Care
- Exchange
- HSDT Nasdaq
- ACHV Nasdaq
- Market Cap
- HSDT 194.2M
- ACHV 167.6M
- IPO Year
- HSDT N/A
- ACHV N/A
- Fundamental
- Price
- HSDT $3.14
- ACHV $3.96
- Analyst Decision
- HSDT
- ACHV Strong Buy
- Analyst Count
- HSDT 0
- ACHV 1
- Target Price
- HSDT N/A
- ACHV $12.00
- AVG Volume (30 Days)
- HSDT 743.1K
- ACHV 747.0K
- Earning Date
- HSDT 11-18-2025
- ACHV 11-06-2025
- Dividend Yield
- HSDT N/A
- ACHV N/A
- EPS Growth
- HSDT N/A
- ACHV N/A
- EPS
- HSDT N/A
- ACHV N/A
- Revenue
- HSDT $295,000.00
- ACHV N/A
- Revenue This Year
- HSDT N/A
- ACHV N/A
- Revenue Next Year
- HSDT $75.13
- ACHV N/A
- P/E Ratio
- HSDT N/A
- ACHV N/A
- Revenue Growth
- HSDT N/A
- ACHV N/A
- 52 Week Low
- HSDT $2.83
- ACHV $1.84
- 52 Week High
- HSDT $1,200.00
- ACHV $5.78
- Technical
- Relative Strength Index (RSI)
- HSDT 27.63
- ACHV 41.02
- Support Level
- HSDT $4.33
- ACHV $4.27
- Resistance Level
- HSDT $5.47
- ACHV $4.45
- Average True Range (ATR)
- HSDT 0.54
- ACHV 0.32
- MACD
- HSDT 0.06
- ACHV -0.15
- Stochastic Oscillator
- HSDT 12.93
- ACHV 10.19
About HSDT Helius Medical Technologies Inc. (DE)
Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities. Through this model, Solana Company provides public market investors with efficient and direct exposure to Solana's long-term growth potential.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.